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Abstract K-Haemolysin is a protein toxin secreted by patho-
genic strains of Escherichia coli and requires sub-millimolar
Ca2+ for optimum lytic activity. As a member of the so-called
RTX toxin family it contains a Gly-rich, Asp-rich Ca2+-binding
domain, consisting of a series of nonapeptides repeated in tan-
dem. Asp-863 is located immediately after the last-but-one non-
apeptide. A mutant in which Asp-863 has been substituted by
Gly displays a requirement for Ca2+ that is 100-fold higher than
the wild-type. Membrane lytic activity, as well as a conforma-
tional change revealed through an increase in intrinsic £uores-
cence, and the appearance of Ca2+-bound protein monomers
resolvable by fast protein liquid chromatography, are all three
dependent on Ca2+ concentrations in the 2^20 mM range. Most
RTX toxins have an Asp or Glu residue located at a position
homologous to Asp-863, thus the key role of this residue for
Ca2+ requirements of K-haemolysin may be a general feature of
this family of toxins.
- 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Escherichia coli K-haemolysin (HlyA) is a member of a
family of Gram-negative bacterial toxins, the so-called RTX
family, characterised by a number of nonapeptides repeated in
tandem near the carboxy-terminus of the protein. RTX toxins
are in turn members of the type I exoprotein secretion system
present in a wide variety of Gram-negative bacteria (see [1^5]
for reviews).
The nonapeptide consensus sequence is GGXGXDXUX,
with U representing a large hydrophobic residue. The non-
apeptide repeat domain is responsible for Ca2þ-binding, and
Ca2þ is required for the lytic activity of HlyA [6^9]. The three-
dimensional structure of the repeats domain of HlyA is still
unknown, but a homologous domain of a non-toxin RTX
protein, alkaline protease from Pseudomonas aeruginosa, has
been solved to high resolution [10], and it can be reasonably
assumed that the structure of the Ca2þ-binding C-terminal
domain of HlyA follows a similar pattern. The core of the
Ca2þ-binding structure consists of a parallel L-roll, built of a
succession of nonapeptide motifs, each of them providing two
half-sites for Ca2þ-binding, so that in the protease seven se-
quence motifs are found, contributing to the binding sites of
¢ve Ca2þ, two or three additional Ca2þ sites being found in
other regions of this domain. As noted by Welch [5], a critical
observation is that the repeats with exact matches to the con-
sensus sequence form the highly regular, ordered central por-
tion of the L-roll, whereas the repeats with approximate
matches to the consensus give rise to frayed edges of the
L-roll. Baumann et al. [10] observed that, at the C-terminal
edge, two Ca2þ ions have one or two H2O ligands in their
octahedral structures, the two being easily exchangeable by
Sr2þ.
HlyA contains 15 nonapeptide repeats in the Ca2þ-binding
domain, thus a large number of Ca2þ-binding sites is to be
expected. In fact in the presence of 3 M urea, when the pro-
tein is presumably in a partially unfolded conformational
state, the binding of up to 12 Ca2þ/protein molecule has
been measured [11]. However, in the absence of urea, only
three high-a⁄nity Ca2þ-binding sites were detected [9], corre-
sponding probably to the easily exchangeable Ca2þ on K-hae-
molysin, i.e. the equivalents to the two exchangeable Ca2þ in
the P. aeruginosa protease [10].
The C-end of the HlyA repeat domain has been the object
of a recent study in this laboratory [12]. In the last-but-one
nonapeptide a His (His-859) occupies the position occupied in
all the other nonapeptides by either Asp or (occasionally)
Asn. Substituting the anomalous His-859 by Asp had virtually
no e¡ect on the lytic activity of the protein, while a HisCAsn
substitution completely abolished the activity, probably be-
cause it shifted the protein monomerHaggregate equilibrium
towards the inactive, aggregated form [12]. In the present
study our attention was drawn by the three consecutive Asp
residues in positions 862^864. On the basis of the neutral
H859D mutant obtained previously [12], a double mutant
(DM HlyA) was obtained in which a D863G substitution
occurred on top of the H859D replacement. This construction
has the advantage of containing a mutation in the Asp-862^
864 triplet while maintaining the same number of Asp resi-
dues, and the same net charge at neutral pH, than the wild-
type (WT). The consequence of these mutations is that the
modi¢ed protein has a much higher (two orders of magnitude)
requirement for Ca2þ, i.e. that DM HlyA is fully active only
at Ca2þ concentrations above 20 mM. The properties of DM
HlyA at 50 mM Ca2þ parallel precisely those of the WT HlyA
at 200 WM Ca2þ. Asp (or Glu) residues homologous to Asp-
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863 occur at the C-terminus of the repeat domain in several
other RTX toxins, and may also regulate the Ca2þ require-
ment of those proteins.
2. Materials and methods
2.1. Materials
Egg phosphatidylcholine (PC) and egg phosphatidylethanolamine
(PE) were obtained from Lipid Products (South Nut¢eld, UK). Horse
erythrocytes were purchased from Microlab (Madrid, Spain). ANTS
(8-aminonaphthalene-1,2,3-trisulphonic acid) and DPX (p-xylene
bis(pyridinium bromine)) were from Molecular Probes (Eugene, OR,
USA). Taq polymerase was supplied by Bioline (London, UK). The
deoxyribonucleotides were from Boehringer Mannheim GmbH
(Mannheim, Germany). The restriction enzymes NcoI and PacI as
well as the T4 DNA ligase were from New England Biolabs (Hert-
fordshire, UK). Oligonucleotides were synthesised by Amersham
Pharmacia Biotech (Uppsala, Sweden).
2.2. Bacterial strains, growth conditions and plasmids
The E. coli D1210 strain was used throughout this work for DNA
manipulation and HlyA expression. The recombinant plasmid
pSU124, containing the hly genes [13], was used to introduce the
mutations into the hlyA gene. E. coli (pSU124) was grown at 37‡C
in LB medium supplemented with 100 Wg/ml of ampicillin in a shaking
bath.
2.3. Preparation, expression and puri¢cation of WT and mutant HlyA
Site-directed mutants of HlyA at His-859 and Asp-863 were ob-
tained by sequential PCR steps [14,15]. Mutations were con¢rmed
by DNA sequencing. WT and H859DD863G were puri¢ed as de-
scribed previously for the WT [16]. The puri¢ed proteins were stored
at 320‡C in 150 mM NaCl, 6 M urea, 20 mM Tris^HCl, pH 7.0.
2.4. Large unilamellar vesicles (LUV)
LUV made of PC:PE:Chol (2:1:1) were prepared by extrusion
through polycarbonate ¢lters (Nuclepore, Pleasanton, CA, USA),
pore size 0.1 Wm. Bu¡er was 150 mM NaCl, 20 mM Tris^HCl, pH
7.0. The diameter of the resulting vesicles was ca. 100 nm, according
to quasi-elastic light scattering measurements. More details on the
preparation of these vesicles can be found in Mayer et al. [17].
2.5. Release of liposomal contents
Leakage of vesicular aqueous contents was assayed according to
Ellens et al. [18] with ANTS and DPX entrapped in the liposomes.
LUV were prepared in 70 mM NaCl, 12.5 mM ANTS, 45 mM DPX,
20 mM Tris^HCl, pH 7.0. Non-entrapped probes were removed pass-
ing the LUV through a Sephadex G-75 column, eluted with 150 mM
NaCl, 20 mM Tris^HCl, pH 7.0. Assays were performed at 100 WM
lipid in a total volume of 1 ml, with continuous stirring, at 25‡C.
Bu¡er was as above, with the addition of CaCl2 at the desired con-
centration. The assay was started by adding 100 nM calcium-free
dialysed HlyA. ANTS £uorescence was recorded continuously
(Vex = 355 nm; Vem = 520 nm). When leakage reached equilibrium,
Triton X-100 was added (¢nal concentration 0.1% w/v) to induce
100% release. Percent release was computed as follows:
% release ¼ ðF f3F 0ÞðF 1003F0ÞU100
where Ff , F100, and F0 were respectively the £uorescence intensity
values observed after addition of HlyA, after addition of Triton
X-100, and before any addition.
2.6. Gel ¢ltration by fast protein liquid chromatography (FPLC)
Gel ¢ltration was performed according to Cortajarena et al. [12] on
a Superdex HR-200 column using an FPLC system (Amersham Phar-
macia, Uppsala, Sweden). The protein was diluted to 1.5 WM, left to
equilibrate for 10 min, then ¢ltered through a 0.45 Wm pore size ¢lter
and injected into the column, that was equilibrated with 150 mM
NaCl, 20 mM Tris^HCl (pH 7.0). Calcium was added, when required,
to the protein and elution bu¡er, at the same concentration. In each
case, 80 Wg protein was injected in 0.5 ml. The column was eluted at
0.5 ml/min, and 1 ml fractions were collected.
2.7. Intrinsic £uorescence measurements
The £uorescence measurements were performed recording emission
spectra in a SLM-Aminco 8.100 (Spectronic Instruments, Rochester,
NY, USA) spectro£uorimeter ¢xing the excitation wavelength at
295 nm, to avoid the tyrosine contribution. The emission was re-
corded between 310 and 400 nm, with slits of 4 nm for both mono-
chromators. The proteins used in the assay were previously dialysed
for 12 h at 4‡C against TCU (NaCl 150 mM, urea 6 M, Tris 20 mM,
pH 7.0) bu¡er, with 0.1 mM EGTA (ethylene-bis(oxyethylenenitrilo)-
tetraacetic acid) (Sigma, St. Louis, MO, USA) to remove cations in
the samples, and then against TCU bu¡er alone for 6 h at 4‡C in
order to remove EGTA. Protein spectra were recorded in TC bu¡er
(NaCl 150 mM, Tris 20 mM, pH 7.0) adding when necessary the
corresponding CaCl2 concentrations under continuous stirring. The
spectra were recorded after binding equilibrium was reached. Dilution
e¡ect was corrected adding to another protein sample equal volumes
of water and recording the corresponding spectra. The following
equation was used to correct the values:
Fpc ¼ FpUFd0Fd
where Fp and Fd are the £uorescence intensities of the protein
sample and the protein used for dilution correction, respectively. Fd0
is the initial signal of the sample used in the dilution correction. To
follow the changes in £uorescence intensity produced by the addition
of the cation, £uorescence intensity at the maximum wavelength was
represented for each protein.
3. Results and discussion
3.1. Membrane lysis assays
The lytic activity of WT and DM HlyA was tested on LUV
loaded with £uorescent probes at increasing Ca2þ concentra-
tions [19,20]. The results are summarised in Fig. 1. DM HlyA
requires ca. 100 times more Ca2þ than WT to induce a com-
parable solute e¥ux (Fig. 1B) so that, at 1 mM Ca2þ used in
our HlyA assays, DM HlyA is totally inactive (Fig. 1A). Full
activity of WT is found in the presence of about 200 WM Ca2þ
[9], while DM HlyA is seen to require ca. 20 mM. When the
haemolytic activities of WT and DM HlyA are assayed on
horse erythrocytes, the same di¡erence in Ca2þ requirement
is found (data not shown). This underlines the importance of
Asp-863 in Ca2þ-binding by HlyA and subsequent conforma-
tional changes leading to the breakdown of the bilayer per-
meability barrier. Note that DM HlyA contains the same
number of Asp residues as WT in the C-terminus of the repeat
domains, since it bears a His-859 Asp in addition to the Asp-
863 Gly substitution. The His-859 Asp mutation alone has no
e¡ect on the a⁄nity of HlyA for Ca2þ [12].
When WT, H859D and DM HlyA are assayed in the pres-
ence of 50 mM Ca2þ, a calcium concentration that permits
full activity of DM HlyA (Fig. 1), the lytic activities of all
three proteins are found to be superimposable. This is shown
in Fig. 2 for the release of liposomal contents induced by WT
and mutant HlyA in the 10^275 nM concentration range.
Thus an increased requirement of Ca2þ appears to be the
only e¡ect of the double mutation with regard to the mem-
brane lytic properties of HlyA.
3.2. Calcium-induced £uorescence changes in HlyA
Calcium-binding to HlyA is accompanied by an increase in
intrinsic £uorescence at ca. 340 nm, i.e. £uorescence emission
due to the protein Trp residues. For WT, the increase in £uo-
rescence intensity reaches a maximum at ca. 0.25 mM Ca2þ
[9]. When the Trp £uorescence intensities of WT and DM
HlyA are recorded at increasing Ca2þ concentrations they
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are seen to increase in parallel up to 1 mM Ca2þ (Fig. 3A). At
higher Ca2þ concentrations, however, the £uorescence inten-
sity of WT remains constant up to 50 mM Ca2þ, while the
£uorescence of DM HlyA undergoes a further increase, reach-
ing a plateau at ca. 10 mM Ca2þ (Fig. 3B). The 1^10 mM
Ca2þ concentration range is precisely the one at which DM
HlyA activity increases from virtually zero to near maximum
(Fig. 1B). Thus the change in £uorescence observed in Fig. 3B
is re£ecting a conformational change that makes DM HlyA
competent for membrane insertion and subsequent loss of
impermeability.
For WT it had been established that Ca2þ-binding in the 0^
250 WM region accompanied a conformational change, de-
tected through changes in intrinsic £uorescence among other
techniques, that in turn allowed the irreversible insertion of
HlyA into the membrane bilayer, followed by membrane leak-
age [9,20^22]. The data in Fig. 3A indicate that DM HlyA
£uorescence changes with Ca2þ concentrations up to 1 mM in
parallel with WT. However, only after a further increase in
£uorescence in the 1^10 mM Ca2þ range (Fig. 3B) is the mu-
tant lytic activity elicited. The £uorescence data suggest that,
for DM HlyA, a second Ca2þ-dependent conformational
change, in the millimolar concentration range, is required
for the lytic activity to be observed.
3.3. Aggregate^monomer equilibrium
Like other RTX toxin proteins, HlyA exists in solution in
equilibrium between the monomeric and aggregated forms
[5,11,16]. As described in a previous paper [12], only the
monomer containing bound Ca2þ appears to be competent
to achieve target membrane insertion and subsequent lysis.
Fig. 1. The calcium requirements of WT and DM HlyA for toxin-
induced release of liposomal aqueous contents. A: Time-course of
release induced by WT and DM HlyA in the presence of 1 or
40 mM Ca2þ. B: Extent of release plotted as a function of Ca2þ
concentration. % Release is measured from plots as shown in Fig.
1A, after 20 min. Liposomes were LUV composed of PC:PE:Chol
(2:1:1). Total lipid concentration was 0.1 mM. Toxin concentration
was 100 nM.
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Fig. 2. Dose^response curves of toxin-induced release of LUV aque-
ous contents. (b) WT HlyA, assayed in 10 mM Ca2þ. (a) H859D,
assayed in 10 nM Ca2þ. (9) DM HlyA, assayed in 50 mM Ca2þ. %
Release is measured from plots as shown in Fig. 1A, after 20 min.
Other details as in Fig. 1.
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Fig. 3. Ca2þ-dependent changes in intrinsic £uorescence intensity of
the toxin. A: Calcium concentrations 0^1 mM. B: Calcium concen-
trations 0^50 mM. (b) WT; (9) DM HlyA.
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Cortajarena et al. [12] optimised an FPLC method to separate
Ca2þ-bound monomers from protein aggregates. Under their
conditions, aggregates eluted at ca. 10 ml, and Ca2þ-bound
monomers at ca. 18 ml. A peak at 18 ml could only be seen
under conditions leading to HlyA lytic activity, i.e. 0.2 mM
Ca2þ for WT. DM HlyA requires Ca2þ concentrations in the
millimolar range to allow the separate elution of a (small)
peak at 18 ml (Fig. 4). This con¢rms the idea that the behav-
iour of DM HlyA as related to membrane lysis parallels that
of WT, except that the mutant requirements for calcium are
greatly increased.
3.4. Sequence homologies
Comparing the sequences of the various toxins of the RTX
family provides the interesting observation that in many cases
an Asp (or Glu) residue occurs in a homologous position to
Asp-863, i.e. immediately after the last, or last-but-one of the
nonapeptide repeats (Fig. 5). This is observed in eight out of
10 RTX toxins whose sequences are known. When the Asp/
Glu residue follows the last-but-one repeat, as in HlyA, or in
E. coli EhxA, or in Bordetella pertussis CyaA, the last repeat
does not follow immediately the previous one, but instead one
or two amino acid residues occur between them (Fig. 5). The
two RTX toxins with no Asp/Glu after the last/last-but-one
nonapeptide, i.e. A. pleuropneumoniae ApxA II and V. cho-
lerae RtxA, are non-haemolytic, but other non-haemolytic
members of the family do have homologues to Asp-863. Con-
sidering the very scarce number of regularities found in the
RTX family of toxins [5], the presence of Asp/Glu after the
last (or last-but-one) nonapeptide repeats in eight of its mem-
bers is a point that deserves consideration. The experimental
data in this paper demonstrate that, in HlyA, this Asp residue
is essential for keeping the Ca2þ requirements of the protein in
the sub-millimolar range (in practice, Ca2þ requirements of
10 mM or higher are equivalent to having an inactive toxin
under physiological conditions). In the absence of experimen-
tal data from the other toxins, the hypothesis can be put
forward that the homologues of HlyA Asp-863 in the other
toxins mentioned in Fig. 5 may also be important in establish-
ing the toxin requirements for calcium ions.
4. Conclusions
Asp-863 is a very important residue for the calcium-depen-
dent lytic activity of HlyA. A double mutant of this RTX
toxin, in which Asp-863 has been mutated to a Gly, and
His-859 has been substituted by Asp, so that the number of
Asp residues and the net charge in that portion of the poly-
peptide remain constant, requires 100-fold higher concentra-
tions of Ca2þ for its lytic activity than the WT. The H859D
Fig. 4. Separation of DM HlyA-Ca monomers by FPLC. Urea- and
calcium-free DM HlyA (1.5 WM) was incubated in the presence of
0 mM (A), 1 mM (B) and 40 mM (C) CaCl2, and gel-¢ltrated
through a Superdex HR-200 column.
Fig. 5. Alignment of the last nonapeptide repeats of RTX toxins.
The Asp/Glu residue at the end of the last (or last-but-one) nona-
peptide is written in bold.
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mutation in itself has no e¡ect on HlyA haemolytic activity or
calcium-binding properties. The range of Ca2þ concentrations
that elicit a lytic activity in the double mutant also induce a
protein conformational change (according to changes in in-
trinsic £uorescence emission), and allow the existence of Ca2þ-
bound toxin monomers, that are supposed to be the species
that binds irreversibly the target membrane. The presence in
most other toxins of the RTX family of Asp or Glu residues
in positions homologous to Asp-863 with respect to the Ca2þ-
binding nonapeptide repeats suggests that the observations in
this paper may have a more general validity.
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